James Osolnick
Editor

Editor

AE

Editor

2022 marks the 20th anniversary of TGen's founding on what at the time was a relatively unknown idea outside the circles of academia and scientific research, precision medicine. The concept of using a person's own genome to diagnose and treat disease at an individual level —to move beyond the one-size-fits-all treatment plans that had dominated the medical landscape for decades, where drugs and therapies considered large groups of people with the same disease, and what worked for the majority. A true public-private partnership, TGen came to fruition through the work of tribal leaders, CEOs, philanthropic trusts, foundations, individuals and university presidents, all united toward an extraordinarily high-risk goal: Forming and funding an institute based on the just-completed Human Genome Project and placing it not in Boston, San Francisco or Washington, D.C., but in Phenix, Arizona.